BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Crit Care Med. Jun 9, 2026; 15(2): 118811
Published online Jun 9, 2026. doi: 10.5492/wjccm.v15.i2.118811
Navigating the veins: A comprehensive review of vasoactive agent infusion via peripheral routes
Omender Singh, Deven Juneja
Omender Singh, Deven Juneja, Institute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi 110017, India
Author contributions: Singh O and Juneja D contributed to conceptualization of the review, data accusation, writing, and reviewing the manuscript; both the authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Deven Juneja, MD, Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, 1 Press Enclave Road, New Delhi 110017, India. devenjuneja@gmail.com
Received: January 12, 2026
Revised: January 17, 2026
Accepted: February 9, 2026
Published online: June 9, 2026
Processing time: 129 Days and 22.6 Hours
Core Tip

Core Tip: Central venous catheters (CVCs) are traditionally used to transfuse vasopressors. However, their insertion is costly, time-consuming, requires expertise and may be associated with serious complications like bleeding and pneumothorax. Emerging evidence suggests that peripheral venous catheters (PVCs) can be safely and effectively used to administer vasopressors. Even though this may help with the rapid initiation of vasopressors and sometimes avoid the need for CVC insertion, the use of PVCs may also lead to minor complications from extravasation of vasopressors. By adopting a safety protocol that includes measures such as careful selection of insertion site and PVC size, limiting the dose and duration of vasopressors, and vigilant monitoring of the infusion site, complications may be further reduced. Safe use of vasopressors via PVCs may have far-reaching clinical implications for managing early septic shock, especially in resource-limited settings.

Write to the Help Desk